NEW YORK, May 15, 2019 (GLOBE NEWSWIRE) -- Progyny, the leading fertility benefits management company, today announced that it was named #30 on CNBC’s seventh annual Disruptor 50 List and is on the list for the third year in a row.
The CNBC Disruptor 50 is an annual ranked list of the most ambitious and innovative companies representing breakthrough ideas from all over the world. The CNBC Disruptor 50 list was selected by CNBC and CNBC.com editorial staff using a proprietary blend of quantitative and qualitative information submitted by over 1,200 nominated companies. Disruptor 50 data partners PitchBook and IBISWorld provided additional quantitative input. CNBC’s Disruptor 50 Advisory Council, a group of 52 leading thinkers in the field of innovation and entrepreneurship, weighted the quantitative criteria and provided additional analysis of qualitative information.
“We are honored and humbled to be listed for the third year in a row. Our rapid growth means that over 1.5 million people now have coverage for the care they need to build the family of their dreams,” said David Schlanger, CEO of Progyny.
Progyny partners with leading self-funded employers to help employees with family building. Progyny’s carve out fertility benefits solution includes access to treatments such as IVF and egg freezing, support for surrogacy and adoption, an integrated pharmacy program, clinical and emotional support through Patient Care Advocates (dedicated fertility experts), and digital tools. Progyny’s program is designed to deliver superior clinical outcomes and has pregnancy success rates, miscarriage rates, and twinning rates that are superior to the national averages. By significantly reducing the rate of twin and triplet births, Progyny is helping to decrease the $26B of medical costs spent annually on preterm birth in the US.
For more information about Progyny, visit www.progyny.com.
For the full list of 2019 CNBC Disruptor 50 companies and methodology, visit CNBC.com/Disruptors.
About Progyny:
Progyny is the leading fertility benefits management company that combines clinical and emotional guidance and support, science, technology, and data to provide comprehensive, inclusive, and effective value-based fertility solutions for self-insured employers.
Progyny’s benefit plans are designed to improve outcomes, shorten time to pregnancy, and reduce total fertility-related costs. Progyny is privately held and is headquartered in New York, NY. Please visit www.progyny.com.